Search - tctmd.com

Displaying 221 - 232 of 232

Sort: Relevancy | Date

News Daily News

Self-Reported Financial Conflicts Have No Effect on Cardiovascular Trial Outcomes

Caitlin E. Cox

February 07, 2013

News Conference News TCT 2012

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

October 26, 2012

News Industry News

NeoChord’s mitral valve repair device to be featured at 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS)

October 25, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Industry News

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

September 22, 2011

News Daily News

Meta-analyses Rarely Report Conflicts of Interest in Underlying Trials

L.A. McKeown

March 07, 2011

News Industry News

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

January 16, 2011

BIO

Yashasvi Chugh, MD

Video

» On Record

On Record: Medical Journals: What's Broken? How to Fix?

May 11, 2018

CME

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

BIO

Advertisement

Self-Reported Financial Conflicts Have No Effect on Cardiovascular Trial Outcomes

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

NeoChord’s mitral valve repair device to be featured at 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS)

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

Meta-analyses Rarely Report Conflicts of Interest in Underlying Trials

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

Yashasvi Chugh, MD

On Record: Medical Journals: What's Broken? How to Fix?

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Matthew Feinstein, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content